{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:58:12Z","timestamp":1776128292126,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T00:00:00Z","timestamp":1521244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["JCYJ20150403091443329"],"award-info":[{"award-number":["JCYJ20150403091443329"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["JCYJ20160429090753103"],"award-info":[{"award-number":["JCYJ20160429090753103"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["JCYJ20170307111334308"],"award-info":[{"award-number":["JCYJ20170307111334308"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011197","name":"Shenzhen Key Laboratory of Neuropsychiatric Modulation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81101922"],"award-info":[{"award-number":["81101922"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.biopha.2018.03.072","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T01:30:22Z","timestamp":1522978222000},"page":"718-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma"],"prefix":"10.1016","volume":"102","author":[{"given":"Xiang","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Jinling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Weijie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoting","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2018.03.072_bib0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrurol.2014.194","article-title":"Landmarks in the diagnosis and treatment of renal cell carcinoma","volume":"11","author":"Bhatt","year":"2014","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2018.03.072_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/jhg.2016.84","article-title":"Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma","volume":"62","author":"Kurozumi","year":"2017","journal-title":"J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.biopha.2018.03.072_bib0015","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.biopha.2018.03.072_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.6004\/jnccn.2015.0022","article-title":"Kidney cancer, version 3.2015","volume":"13","author":"Motzer","year":"2015","journal-title":"J. Natl. Compr. Cancer Netw.: JNCCN"},{"issue":"1","key":"10.1016\/j.biopha.2018.03.072_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.biopha.2018.03.072_bib0030","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.3892\/mmr.2016.5205","article-title":"Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma","volume":"13","author":"Jin","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1\u20136","key":"10.1016\/j.biopha.2018.03.072_bib0035","first-page":"461","article-title":"Renal cell carcinoma","volume":"9","author":"Cairns","year":"2010","journal-title":"Cancer Biomark. Sect. A: Dis. Markers"},{"issue":"2","key":"10.1016\/j.biopha.2018.03.072_bib0040","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.2016161225","article-title":"Renal cell carcinoma: comparison of RENAL nephrometry and PADUA scores with maximum tumor diameter for prediction of local recurrence after thermal ablation","volume":"283","author":"Maxwell","year":"2017","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.biopha.2018.03.072_bib0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","article-title":"MicroRNA in prostate, bladder, and kidney cancer: a systematic review","volume":"59","author":"Catto","year":"2011","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.biopha.2018.03.072_bib0050","first-page":"235","article-title":"microRNAs and ceRNAs: RNA networks in pathogenesis of cancer","volume":"25","author":"Su","year":"2013","journal-title":"Chin. J. Cancer Res.=Chung-kuo yen cheng yen chiu"},{"key":"10.1016\/j.biopha.2018.03.072_bib0055","first-page":"475","article-title":"MicroRNAs as biomarkers associated with bladder cancer","volume":"30","author":"Homami","year":"2016","journal-title":"Med. J. Islam. Repub. Iran"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.03.072_bib0060","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.4111\/icu.2016.57.S1.S60","article-title":"The role of microRNAs in bladder cancer","volume":"57","author":"Enokida","year":"2016","journal-title":"Invest. Clin. Urol."},{"issue":"1J2","key":"10.1016\/j.biopha.2018.03.072_bib0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-017-3102-1","article-title":"MiRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1","volume":"437","author":"Fu","year":"2018","journal-title":"Mol. Cell. Biochem."},{"issue":"38","key":"10.1016\/j.biopha.2018.03.072_bib0070","doi-asserted-by":"crossref","first-page":"64106","DOI":"10.18632\/oncotarget.19329","article-title":"miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.03.072_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1476-4598-13-63","article-title":"MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab","volume":"13","author":"Zhang","year":"2014","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2018.03.072_bib0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3892\/mmr.2015.4537","article-title":"MicroRNA566 modulates vascular endothelial growth factor by targeting Von Hippel-Landau in human glioblastoma in vitro and in vivo","volume":"13","author":"Xiao","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2018.03.072_bib0085","doi-asserted-by":"crossref","first-page":"e96670","DOI":"10.1371\/journal.pone.0096670","article-title":"MicroRNA profiles discriminate among colon cancer metastasis","volume":"9","author":"Drusco","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.biopha.2018.03.072_bib0090","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4161\/cbt.26370","article-title":"Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma","volume":"14","author":"Rani","year":"2013","journal-title":"Cancer Biol. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2018.03.072_bib0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112495","article-title":"MicroRNAs associated with Von Hippel-Lindau pathway in renal cell carcinoma: a comprehensive review","volume":"18","author":"Schanza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2018.03.072_bib0100","first-page":"45","article-title":"Renal cell carcinoma: links and risks","volume":"9","author":"Kabaria","year":"2016","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1016\/j.biopha.2018.03.072_bib0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ctrv.2017.09.004","article-title":"Adjuvant therapy in renal cell carcinoma","volume":"60","author":"Massari","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2018.03.072_bib0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3322\/caac.21411","article-title":"Treatment of renal cell carcinoma: current status and future directions","volume":"67","author":"Barata","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2018.03.072_bib0115","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1038\/srep07610","article-title":"A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2018.03.072_bib0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/ijo.2013.2169","article-title":"Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma","volume":"44","author":"Iwamoto","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2018.03.072_bib0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00432-013-1577-z","article-title":"miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma","volume":"140","author":"Lu","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.03.072_bib0130","article-title":"Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression","author":"Di Ruocco","year":"2017","journal-title":"Oncogene"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218310230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218310230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:05:18Z","timestamp":1731427518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218310230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":26,"alternative-id":["S0753332218310230"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.072","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}